News
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
12mon MSN
With schools across Karnataka set to reopen in June, the state government has rolled out a new set of Covid-19 safety ...
The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...
This conflicts with guidance from Health and Human Services Secretary Robert F. Kennedy Jr., an anti-vaccine advocate, who is ...
Karnataka school reopening in June prompts govt to issue COVID guidelines for students and staff as cases rise; 114 new ...
Coronavirus vaccines are still recommended for healthy children if their doctors approve, according to updated immunization schedules published late ...
Ab Hernandez Clovis row explained: Why Trump wants transgender athlete banned from California State Championship for girls?
Moderna Covid vaccine approved for those 12-64 with risk factors Moderna expects mNEXSPIKE to be ready for 2025-2026 season Vaccine easier to distribute in ...
I am a cancer survivor. If it weren’t for continuing medical research, I would not be alive today. Both the research and development of microsurgery and chemotherapy were instrumental in me being ...
It has budgeted R35.2 billion to pay the grant in this financial year, while also appealing a high court ruling that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results